1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Respiratory Disorders Drug Market Size by Type: 2016 VS 2021 VS 2027 1.2.2 Capsule 1.2.3 Suspension Agent 1.2.4 Injection 1.2.5 Gas (Powder) Mist 1.2.6 Tablets 1.2.7 Solution 1.2.8 Granules 1.2.9 Dropping Pill 1.2.10 Patch 1.2.11 Other 1.3 Market by Application 1.3.1 Global Respiratory Disorders Drug Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Clearing Away Heat And Detoxifying Drugs 1.3.3 Expectorant 1.3.4 Cold Medicine 1.3.5 Antiasthmatic 1.3.6 COPD Treatment Medicine 1.3.7 Cough Medicine 1.3.8 Respiratory Stimulant 1.3.9 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trend 2.1 Global Respiratory Disorders Drug Market Perspective (2016-2027) 2.2 Global Respiratory Disorders Drug Growth Trends by Regions 2.2.1 Respiratory Disorders Drug Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Respiratory Disorders Drug Historic Market Size by Regions (2016-2021) 2.2.3 Respiratory Disorders Drug Forecasted Market Size by Regions (2022-2027) 2.3 Industry Trends and Growth Strategy 2.3.1 Respiratory Disorders Drug Industry Trends 2.3.2 Respiratory Disorders Drug Market Drivers 2.3.3 Respiratory Disorders Drug Market Challenges 2.3.4 Respiratory Disorders Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Respiratory Disorders Drug Players by Market Size 3.1.1 Players Covered: Ranking by Respiratory Disorders Drug Revenue 3.1.2 Global Top Respiratory Disorders Drug Players by Revenue (2016-2021) 3.1.3 Global Respiratory Disorders Drug Revenue Market Share by Players (2016-2021) 3.1.4 Global Respiratory Disorders Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Respiratory Disorders Drug Market Concentration Ratio 3.2.1 Global Respiratory Disorders Drug Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 5 and Top 10 Players by Respiratory Disorders Drug Revenue in 2020 3.3 Respiratory Disorders Drug Key Players Head office and Area Served 3.4 Key Players Respiratory Disorders Drug Product Solution and Service 3.5 Date of Enter into Respiratory Disorders Drug Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Global Respiratory Disorders Drug Breakdown Data by Type (2016-2027) 4.1 Global Respiratory Disorders Drug Historic Market Size by Type (2016-2021) 4.2 Global Respiratory Disorders Drug Forecasted Market Size by Type (2022-2027) 5 Global Respiratory Disorders Drug Breakdown Data by Application (2016-2027) 5.1 Global Respiratory Disorders Drug Historic Market Size by Application (2016-2021) 5.2 Respiratory Disorders Drug Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Respiratory Disorders Drug Market Size (2016-2027) 6.2 Key Respiratory Disorders Drug Players Market Share in North America (2020-2021) 6.3 North America Respiratory Disorders Drug Market Size by Country 6.3.1 North America Respiratory Disorders Drug Market Size by Country (2016-2021) 6.3.2 North America Respiratory Disorders Drug Market Size Forecast by Country (2022-2027) 6.4 U.S. Market Size Analysis 6.4.1 U.S. Respiratory Disorders Drug Market Size (2016-2027) 6.4.2 U.S. Respiratory Disorders Drug Market Size by Type (2016-2027) 6.4.3 U.S. Respiratory Disorders Drug Market Size by Application (2016-2027) 6.5 Canada Market Size Analysis 6.5.1 Canada Respiratory Disorders Drug Market Size (2016-2027) 6.5.2 Canada Respiratory Disorders Drug Market Size by Type (2016-2027) 6.5.3 Canada Respiratory Disorders Drug Market Size by Application (2016-2027) 7 Europe 7.1 Europe Respiratory Disorders Drug Market Size (2016-2027) 7.2 Key Respiratory Disorders Drug Players Market Share in Europe (2020-2021) 7.3 Europe Respiratory Disorders Drug Market Size by Country 7.3.1 Europe Respiratory Disorders Drug Market Size by Country (2016-2021) 7.3.2 Europe Respiratory Disorders Drug Market Size Forecast by Country (2022-2027) 7.4 Germany Market Size Analysis 7.4.1 Germany Respiratory Disorders Drug Market Size (2016-2027) 7.4.2 Germany Respiratory Disorders Drug Market Size by Type (2016-2027) 7.4.3 Germany Respiratory Disorders Drug Market Size by Application (2016-2027) 7.5 France Market Size Analysis 7.5.1 France Respiratory Disorders Drug Market Size (2016-2027) 7.5.2 France Respiratory Disorders Drug Market Size by Type (2016-2027) 7.5.3 France Respiratory Disorders Drug Market Size by Application (2016-2027) 7.6 U.K. Market Size Analysis 7.6.1 U.K. Respiratory Disorders Drug Market Size (2016-2027) 7.6.2 U.K. Respiratory Disorders Drug Market Size by Type (2016-2027) 7.6.3 U.K. Respiratory Disorders Drug Market Size by Application (2016-2027) 7.7 Italy Market Size Analysis 7.7.1 Italy Respiratory Disorders Drug Market Size (2016-2027) 7.7.2 Italy Respiratory Disorders Drug Market Size by Type (2016-2027) 7.7.3 Italy Respiratory Disorders Drug Market Size by Application (2016-2027) 7.8 Russia Market Size Analysis 7.8.1 Russia Respiratory Disorders Drug Market Size (2016-2027) 7.8.2 Russia Respiratory Disorders Drug Market Size by Type (2016-2027) 7.8.3 Russia Respiratory Disorders Drug Market Size by Application (2016-2027) 8 Asia-Pacific 8.1 Asia-Pacific Respiratory Disorders Drug Market Size (2016-2027) 8.2 Key Respiratory Disorders Drug Players Market Share in Asia-Pacific (2020-2021) 8.3 Asia-Pacific Respiratory Disorders Drug Market Size by Region 8.3.1 Asia-Pacific Respiratory Disorders Drug Market Size by Region (2016-2021) 8.3.2 Asia-Pacific Respiratory Disorders Drug Market Size Forecast by Region (2022-2027) 8.4 China Market Size Analysis 8.4.1 China Respiratory Disorders Drug Market Size (2016-2027) 8.4.2 China Respiratory Disorders Drug Market Size by Type (2016-2027) 8.4.3 China Respiratory Disorders Drug Market Size by Application (2016-2027) 8.5 Japan Market Size Analysis 8.5.1 Japan Respiratory Disorders Drug Market Size (2016-2027) 8.5.2 Japan Respiratory Disorders Drug Market Size by Type (2016-2027) 8.5.3 Japan Respiratory Disorders Drug Market Size by Application (2016-2027) 8.6 South Korea Market Size Analysis 8.6.1 South Korea Respiratory Disorders Drug Market Size (2016-2027) 8.6.2 South Korea Respiratory Disorders Drug Market Size by Type (2016-2027) 8.6.3 South Korea Respiratory Disorders Drug Market Size by Application (2016-2027) 8.7 India Market Size Analysis 8.7.1 India Respiratory Disorders Drug Market Size (2016-2027) 8.7.2 India Respiratory Disorders Drug Market Size by Type (2016-2027) 8.7.3 India Respiratory Disorders Drug Market Size by Application (2016-2027) 8.8 Australia Market Size Analysis 8.8.1 Australia Respiratory Disorders Drug Market Size (2016-2027) 8.8.2 Australia Respiratory Disorders Drug Market Size by Type (2016-2027) 8.8.3 Australia Respiratory Disorders Drug Market Size by Application (2016-2027) 8.9 Taiwan Market Size Analysis 8.9.1 Taiwan Respiratory Disorders Drug Market Size (2016-2027) 8.9.2 Taiwan Respiratory Disorders Drug Market Size by Type (2016-2027) 8.9.3 Taiwan Respiratory Disorders Drug Market Size by Application (2016-2027) 8.10 Indonesia Market Size Analysis 8.10.1 Indonesia Respiratory Disorders Drug Market Size (2016-2027) 8.10.2 Indonesia Respiratory Disorders Drug Market Size by Type (2016-2027) 8.10.3 Indonesia Respiratory Disorders Drug Market Size by Application (2016-2027) 8.11 Thailand Market Size Analysis 8.11.1 Thailand Respiratory Disorders Drug Market Size (2016-2027) 8.11.2 Thailand Respiratory Disorders Drug Market Size by Type (2016-2027) 8.11.3 Thailand Respiratory Disorders Drug Market Size by Application (2016-2027) 8.12 Malaysia Market Size Analysis 8.12.1 Malaysia Respiratory Disorders Drug Market Size (2016-2027) 8.12.2 Malaysia Respiratory Disorders Drug Market Size by Type (2016-2027) 8.12.3 Malaysia Respiratory Disorders Drug Market Size by Application (2016-2027) 8.13 Philippines Market Size Analysis 8.13.1 Philippines Respiratory Disorders Drug Market Size (2016-2027) 8.13.2 Philippines Respiratory Disorders Drug Market Size by Type (2016-2027) 8.13.3 Philippines Respiratory Disorders Drug Market Size by Application (2016-2027) 8.14 Vietnam Market Size Analysis 8.14.1 Vietnam Respiratory Disorders Drug Market Size (2016-2027) 8.14.2 Vietnam Respiratory Disorders Drug Market Size by Type (2016-2027) 8.14.3 Vietnam Respiratory Disorders Drug Market Size by Application (2016-2027) 9 Latin America 9.1 Latin America Respiratory Disorders Drug Market Size (2016-2027) 9.2 Key Respiratory Disorders Drug Players Market Share in Latin America (2020-2021) 9.3 Latin America Respiratory Disorders Drug Market Size by Country 9.3.1 Latin America Respiratory Disorders Drug Market Size by Country (2016-2021) 9.3.2 Latin America Respiratory Disorders Drug Market Size Forecast by Country (2022-2027) 9.4 Mexico Market Size Analysis 9.4.1 Mexico Respiratory Disorders Drug Market Size (2016-2027) 9.4.2 Mexico Respiratory Disorders Drug Market Size by Type (2016-2027) 9.4.3 Mexico Respiratory Disorders Drug Market Size by Application (2016-2027) 9.5 Brazil Market Size Analysis 9.5.1 Brazil Respiratory Disorders Drug Market Size (2016-2027) 9.5.2 Brazil Respiratory Disorders Drug Market Size by Type (2016-2027) 9.5.3 Brazil Respiratory Disorders Drug Market Size by Application (2016-2027) 9.6 Argentina Market Size Analysis 9.6.1 Argentina Respiratory Disorders Drug Market Size (2016-2027) 9.6.2 Argentina Respiratory Disorders Drug Market Size by Type (2016-2027) 9.6.3 Argentina Respiratory Disorders Drug Market Size by Application (2016-2027) 10 Middle East & Africa 10.1 Middle East & Africa Respiratory Disorders Drug Market Size (2016-2027) 10.2 Key Respiratory Disorders Drug Players Market Share in Middle East & Africa (2020-2021) 10.3 Middle East & Africa Respiratory Disorders Drug Market Size by Country 10.3.1 Middle East & Africa Respiratory Disorders Drug Market Size by Country (2016-2021) 10.3.2 Middle East & Africa Respiratory Disorders Drug Market Size Forecast by Country (2022-2027) 10.4 Turkey Market Size Analysis 10.4.1 Turkey Respiratory Disorders Drug Market Size (2016-2027) 10.4.2 Turkey Respiratory Disorders Drug Market Size by Type (2016-2027) 10.4.3 Turkey Respiratory Disorders Drug Market Size by Application (2016-2027) 10.5 Saudi Arabia Market Size Analysis 10.5.1 Saudi Arabia Respiratory Disorders Drug Market Size (2016-2027) 10.5.2 Saudi Arabia Respiratory Disorders Drug Market Size by Type (2016-2027) 10.5.3 Saudi Arabia Respiratory Disorders Drug Market Size by Application (2016-2027) 10.6 UAE Market Size Analysis 10.6.1 UAE Respiratory Disorders Drug Market Size (2016-2027) 10.6.2 UAE Respiratory Disorders Drug Market Size by Type (2016-2027) 10.6.3 UAE Respiratory Disorders Drug Market Size by Application (2016-2027) 11 Key Players Profiles 11.1 AstraZeneca 11.1.1 AstraZeneca Company Details 11.1.2 AstraZeneca Business Overview and Its Total Revenue 11.1.3 AstraZeneca Respiratory Disorders Drug Introduction 11.1.4 AstraZeneca Revenue in Respiratory Disorders Drug Business (2016-2021) 11.1.5 AstraZeneca Recent Development 11.2 MSD 11.2.1 MSD Company Details 11.2.2 MSD Business Overview and Its Total Revenue 11.2.3 MSD Respiratory Disorders Drug Introduction 11.2.4 MSD Revenue in Respiratory Disorders Drug Business (2016-2021) 11.2.5 MSD Recent Development 11.3 Boehringer Ingelheim 11.3.1 Boehringer Ingelheim Company Details 11.3.2 Boehringer Ingelheim Business Overview and Its Total Revenue 11.3.3 Boehringer Ingelheim Respiratory Disorders Drug Introduction 11.3.4 Boehringer Ingelheim Revenue in Respiratory Disorders Drug Business (2016-2021) 11.3.5 Boehringer Ingelheim Recent Development 11.4 Biogen 11.4.1 Biogen Company Details 11.4.2 Biogen Business Overview and Its Total Revenue 11.4.3 Biogen Respiratory Disorders Drug Introduction 11.4.4 Biogen Revenue in Respiratory Disorders Drug Business (2016-2021) 11.4.5 Biogen Recent Development 11.5 Pfizer 11.5.1 Pfizer Company Details 11.5.2 Pfizer Business Overview and Its Total Revenue 11.5.3 Pfizer Respiratory Disorders Drug Introduction 11.5.4 Pfizer Revenue in Respiratory Disorders Drug Business (2016-2021) 11.5.5 Pfizer Recent Development 11.6 Teva 11.6.1 Teva Company Details 11.6.2 Teva Business Overview and Its Total Revenue 11.6.3 Teva Respiratory Disorders Drug Introduction 11.6.4 Teva Revenue in Respiratory Disorders Drug Business (2016-2021) 11.6.5 Teva Recent Development 11.7 Novartis 11.7.1 Novartis Company Details 11.7.2 Novartis Business Overview and Its Total Revenue 11.7.3 Novartis Respiratory Disorders Drug Introduction 11.7.4 Novartis Revenue in Respiratory Disorders Drug Business (2016-2021) 11.7.5 Novartis Recent Development 11.8 Johnson & Johnson 11.8.1 Johnson & Johnson Company Details 11.8.2 Johnson & Johnson Business Overview and Its Total Revenue 11.8.3 Johnson & Johnson Respiratory Disorders Drug Introduction 11.8.4 Johnson & Johnson Revenue in Respiratory Disorders Drug Business (2016-2021) 11.8.5 Johnson & Johnson Recent Development 11.9 Eli Lilly 11.9.1 Eli Lilly Company Details 11.9.2 Eli Lilly Business Overview and Its Total Revenue 11.9.3 Eli Lilly Respiratory Disorders Drug Introduction 11.9.4 Eli Lilly Revenue in Respiratory Disorders Drug Business (2016-2021) 11.9.5 Eli Lilly Recent Development 11.10 Otsuka 11.10.1 Otsuka Company Details 11.10.2 Otsuka Business Overview and Its Total Revenue 11.10.3 Otsuka Respiratory Disorders Drug Introduction 11.10.4 Otsuka Revenue in Respiratory Disorders Drug Business (2016-2021) 11.10.5 Otsuka Recent Development 11.11 Merck 11.11.1 Merck Company Details 11.11.2 Merck Business Overview and Its Total Revenue 11.11.3 Merck Respiratory Disorders Drug Introduction 11.11.4 Merck Revenue in Respiratory Disorders Drug Business (2016-2021) 11.11.5 Merck Recent Development 11.12 Takeda 11.12.1 Takeda Company Details 11.12.2 Takeda Business Overview and Its Total Revenue 11.12.3 Takeda Respiratory Disorders Drug Introduction 11.12.4 Takeda Revenue in Respiratory Disorders Drug Business (2016-2021) 11.12.5 Takeda Recent Development 11.13 FibroGen 11.13.1 FibroGen Company Details 11.13.2 FibroGen Business Overview and Its Total Revenue 11.13.3 FibroGen Respiratory Disorders Drug Introduction 11.13.4 FibroGen Revenue in Respiratory Disorders Drug Business (2016-2021) 11.13.5 FibroGen Recent Development 11.14 Amgen 11.14.1 Amgen Company Details 11.14.2 Amgen Business Overview and Its Total Revenue 11.14.3 Amgen Respiratory Disorders Drug Introduction 11.14.4 Amgen Revenue in Respiratory Disorders Drug Business (2016-2021) 11.14.5 Amgen Recent Development 11.15 Dr. Reddy's Laboratories 11.15.1 Dr. Reddy's Laboratories Company Details 11.15.2 Dr. Reddy's Laboratories Business Overview and Its Total Revenue 11.15.3 Dr. Reddy's Laboratories Respiratory Disorders Drug Introduction 11.15.4 Dr. Reddy's Laboratories Revenue in Respiratory Disorders Drug Business (2016-2021) 11.15.5 Dr. Reddy's Laboratories Recent Development 11.16 Dainippon Sumitomo 11.16.1 Dainippon Sumitomo Company Details 11.16.2 Dainippon Sumitomo Business Overview and Its Total Revenue 11.16.3 Dainippon Sumitomo Respiratory Disorders Drug Introduction 11.16.4 Dainippon Sumitomo Revenue in Respiratory Disorders Drug Business (2016-2021) 11.16.5 Dainippon Sumitomo Recent Development 11.17 Abbott 11.17.1 Abbott Company Details 11.17.2 Abbott Business Overview and Its Total Revenue 11.17.3 Abbott Respiratory Disorders Drug Introduction 11.17.4 Abbott Revenue in Respiratory Disorders Drug Business (2016-2021) 11.17.5 Abbott Recent Development 11.18 Horizon Pharma 11.18.1 Horizon Pharma Company Details 11.18.2 Horizon Pharma Business Overview and Its Total Revenue 11.18.3 Horizon Pharma Respiratory Disorders Drug Introduction 11.18.4 Horizon Pharma Revenue in Respiratory Disorders Drug Business (2016-2021) 11.18.5 Horizon Pharma Recent Development 11.19 Zambon 11.19.1 Zambon Company Details 11.19.2 Zambon Business Overview and Its Total Revenue 11.19.3 Zambon Respiratory Disorders Drug Introduction 11.19.4 Zambon Revenue in Respiratory Disorders Drug Business (2016-2021) 11.19.5 Zambon Recent Development 11.20 Moehs 11.20.1 Moehs Company Details 11.20.2 Moehs Business Overview and Its Total Revenue 11.20.3 Moehs Respiratory Disorders Drug Introduction 11.20.4 Moehs Revenue in Respiratory Disorders Drug Business (2016-2021) 11.20.5 Moehs Recent Development 11.21 Pharmazell 11.21.1 Pharmazell Company Details 11.21.2 Pharmazell Business Overview and Its Total Revenue 11.21.3 Pharmazell Respiratory Disorders Drug Introduction 11.21.4 Pharmazell Revenue in Respiratory Disorders Drug Business (2016-2021) 11.21.5 Pharmazell Recent Development 11.22 Nippon Rika 11.22.1 Nippon Rika Company Details 11.22.2 Nippon Rika Business Overview and Its Total Revenue 11.22.3 Nippon Rika Respiratory Disorders Drug Introduction 11.22.4 Nippon Rika Revenue in Respiratory Disorders Drug Business (2016-2021) 11.22.5 Nippon Rika Recent Development 11.23 Chengyi Pharma 11.23.1 Chengyi Pharma Company Details 11.23.2 Chengyi Pharma Business Overview and Its Total Revenue 11.23.3 Chengyi Pharma Respiratory Disorders Drug Introduction 11.23.4 Chengyi Pharma Revenue in Respiratory Disorders Drug Business (2016-2021) 11.23.5 Chengyi Pharma Recent Development 11.24 Wuhan Grand Hoyo 11.24.1 Wuhan Grand Hoyo Company Details 11.24.2 Wuhan Grand Hoyo Business Overview and Its Total Revenue 11.24.3 Wuhan Grand Hoyo Respiratory Disorders Drug Introduction 11.24.4 Wuhan Grand Hoyo Revenue in Respiratory Disorders Drug Business (2016-2021) 11.24.5 Wuhan Grand Hoyo Recent Development 11.25 Manus Aktteva Biopharma 11.25.1 Manus Aktteva Biopharma Company Details 11.25.2 Manus Aktteva Biopharma Business Overview and Its Total Revenue 11.25.3 Manus Aktteva Biopharma Respiratory Disorders Drug Introduction 11.25.4 Manus Aktteva Biopharma Revenue in Respiratory Disorders Drug Business (2016-2021) 11.25.5 Manus Aktteva Biopharma Recent Development 11.26 Beijing Jiuhe Pharmaceutical 11.26.1 Beijing Jiuhe Pharmaceutical Company Details 11.26.2 Beijing Jiuhe Pharmaceutical Business Overview and Its Total Revenue 11.26.3 Beijing Jiuhe Pharmaceutical Respiratory Disorders Drug Introduction 11.26.4 Beijing Jiuhe Pharmaceutical Revenue in Respiratory Disorders Drug Business (2016-2021) 11.26.5 Beijing Jiuhe Pharmaceutical Recent Development 11.27 Daiichi Sankyo Pharmaceutical 11.27.1 Daiichi Sankyo Pharmaceutical Company Details 11.27.2 Daiichi Sankyo Pharmaceutical Business Overview and Its Total Revenue 11.27.3 Daiichi Sankyo Pharmaceutical Respiratory Disorders Drug Introduction 11.27.4 Daiichi Sankyo Pharmaceutical Revenue in Respiratory Disorders Drug Business (2016-2021) 11.27.5 Daiichi Sankyo Pharmaceutical Recent Development 11.28 Sinopharm 11.28.1 Sinopharm Company Details 11.28.2 Sinopharm Business Overview and Its Total Revenue 11.28.3 Sinopharm Respiratory Disorders Drug Introduction 11.28.4 Sinopharm Revenue in Respiratory Disorders Drug Business (2016-2021) 11.28.5 Sinopharm Recent Development 11.29 CTTQ 11.29.1 CTTQ Company Details 11.29.2 CTTQ Business Overview and Its Total Revenue 11.29.3 CTTQ Respiratory Disorders Drug Introduction 11.29.4 CTTQ Revenue in Respiratory Disorders Drug Business (2016-2021) 11.29.5 CTTQ Recent Development 11.30 Yangtze River Pharmaceutical Group 11.30.1 Yangtze River Pharmaceutical Group Company Details 11.30.2 Yangtze River Pharmaceutical Group Business Overview and Its Total Revenue 11.30.3 Yangtze River Pharmaceutical Group Respiratory Disorders Drug Introduction 11.30.4 Yangtze River Pharmaceutical Group Revenue in Respiratory Disorders Drug Business (2016-2021) 11.30.5 Yangtze River Pharmaceutical Group Recent Development 12 Analyst's Viewpoints/Conclusion 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Respiratory Disorders Drug Market Size Growth Rate by Type (US$ Million): 2016 VS 2021 VS 2027 Table 2. Key Players of Capsule Table 3. Key Players of Suspension Agent Table 4. Key Players of Injection Table 5. Key Players of Gas (Powder) Mist Table 6. Key Players of Tablets Table 7. Key Players of Solution Table 8. Key Players of Granules Table 9. Key Players of Dropping Pill Table 10. Key Players of Patch Table 11. Global Respiratory Disorders Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 12. Global Respiratory Disorders Drug Market Size by Region (US$ Million): 2016 VS 2021 VS 2027 Table 13. Global Respiratory Disorders Drug Market Size by Regions (2016-2021) & (US$ Million) Table 14. Global Respiratory Disorders Drug Market Share by Regions (2016-2021) Table 15. Global Respiratory Disorders Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 16. Global Respiratory Disorders Drug Market Share by Regions (2022-2027) Table 17. Respiratory Disorders Drug Market Trends Table 18. Respiratory Disorders Drug Market Drivers Table 19. Respiratory Disorders Drug Market Challenges Table 20. Respiratory Disorders Drug Market Restraints Table 21. Ranking of Global Top Respiratory Disorders Drug Manufacturers by Revenue (US$ Million) in 2020 Table 22. Global Respiratory Disorders Drug Revenue by Players (2016-2021) & (US$ Million) Table 23. Global Respiratory Disorders Drug Market Share by Players (2016-2021) Table 24. Global Top Respiratory Disorders Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Disorders Drug as of 2020) Table 25. Global 5 Largest Players Market Share by Respiratory Disorders Drug Revenue (CR5 and HHI) (2016-2021) Table 26. Key Players Headquarters and Area Served Table 27. Key Players Respiratory Disorders Drug Product Solution and Service Table 28. Date of Enter into Respiratory Disorders Drug Market Table 29. Mergers & Acquisitions, Expansion Plans Table 30. Global Respiratory Disorders Drug Market Size by Type (2016-2021) & (US$ Million) Table 31. Global Respiratory Disorders Drug Revenue Market Share by Type (2016-2021) Table 32. Global Respiratory Disorders Drug Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 33. Global Respiratory Disorders Drug Revenue Market Share by Type (2022-2027) Table 34. Global Respiratory Disorders Drug Market Size by Application (2016-2021) & (US$ Million) Table 35. Global Respiratory Disorders Drug Revenue Market Share by Application (2016-2021) Table 36. Global Respiratory Disorders Drug Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 37. Global Respiratory Disorders Drug Revenue Market Share by Application (2022-2027) Table 38. Key Players Respiratory Disorders Drug Revenue in North America (2020-2021) (US$ Million) Table 39. North America Respiratory Disorders Drug Market Size by Countries (2016-2021) & (US$ Million) Table 40. North America Respiratory Disorders Drug Market Size Share by Countries (2016-2021) Table 41. North America Respiratory Disorders Drug Market Size by Countries (2022-2027) & (US$ Million) Table 42. North America Respiratory Disorders Drug Market Size Share by Countries (2022-2027) Table 43. Respiratory Disorders Drug Market Size (US$ Million) in U.S., Breakdown by Type (2016-2021) Table 44. Respiratory Disorders Drug Market Size (US$ Million) in U.S., Breakdown by Type (2022-2027) Table 45. Respiratory Disorders Drug Market Size (US$ Million) in U.S., Breakdown by Application (2016-2021) Table 46. Respiratory Disorders Drug Market Size (US$ Million) in U.S., Breakdown by Application (2022-2027) Table 47. Respiratory Disorders Drug Market Size (US$ Million) in Canada, Breakdown by Type (2016-2021) Table 48. Respiratory Disorders Drug Market Size (US$ Million) in Canada, Breakdown by Type (2022-2027) Table 49. Respiratory Disorders Drug Market Size (US$ Million) in Canada, Breakdown by Application (2016-2021) Table 50. Respiratory Disorders Drug Market Size (US$ Million) in Canada, Breakdown by Application (2022-2027) Table 51. Key Players Respiratory Disorders Drug Revenue in Europe (2020-2021) (US$ Million) Table 52. Europe Respiratory Disorders Drug Market Size by Countries (2016-2021) & (US$ Million) Table 53. Europe Respiratory Disorders Drug Market Size Share by Countries (2016-2021) Table 54. Europe Respiratory Disorders Drug Market Size by Countries (2022-2027) & (US$ Million) Table 55. Europe Respiratory Disorders Drug Market Size Share by Countries (2022-2027) Table 56. Respiratory Disorders Drug Market Size (US$ Million) in Germany, Breakdown by Type (2016-2021) Table 57. Respiratory Disorders Drug Market Size (US$ Million) in Germany, Breakdown by Type (2022-2027) Table 58. Respiratory Disorders Drug Market Size (US$ Million) in Germany, Breakdown by Application (2016-2021) Table 59. Respiratory Disorders Drug Market Size (US$ Million) in Germany, Breakdown by Application (2022-2027) Table 60. Respiratory Disorders Drug Market Size (US$ Million) in France, Breakdown by Type (2016-2021) Table 61. Respiratory Disorders Drug Market Size (US$ Million) in France, Breakdown by Type (2022-2027) Table 62. Respiratory Disorders Drug Market Size (US$ Million) in France, Breakdown by Application (2016-2021) Table 63. Respiratory Disorders Drug Market Size (US$ Million) in France, Breakdown by Application (2022-2027) Table 64. Respiratory Disorders Drug Market Size (US$ Million) in U.K., Breakdown by Type (2016-2021) Table 65. Respiratory Disorders Drug Market Size (US$ Million) in U.K., Breakdown by Type (2022-2027) Table 66. Respiratory Disorders Drug Market Size (US$ Million) in U.K., Breakdown by Application (2016-2021) Table 67. Respiratory Disorders Drug Market Size (US$ Million) in U.K., Breakdown by Application (2022-2027) Table 68. Respiratory Disorders Drug Market Size (US$ Million) in Italy, Breakdown by Type (2016-2021) Table 69. Respiratory Disorders Drug Market Size (US$ Million) in Italy, Breakdown by Type (2022-2027) Table 70. Respiratory Disorders Drug Market Size (US$ Million) in Italy, Breakdown by Application (2016-2021) Table 71. Respiratory Disorders Drug Market Size (US$ Million) in Italy, Breakdown by Application (2022-2027) Table 72. Respiratory Disorders Drug Market Size (US$ Million) in Russia, Breakdown by Type (2016-2021) Table 73. Respiratory Disorders Drug Market Size (US$ Million) in Russia, Breakdown by Type (2022-2027) Table 74. Respiratory Disorders Drug Market Size (US$ Million) in Russia, Breakdown by Application (2016-2021) Table 75. Respiratory Disorders Drug Market Size (US$ Million) in Russia, Breakdown by Application (2022-2027) Table 76. Key Players Respiratory Disorders Drug Revenue in Asia-Pacific (2020-2021) (US$ Million) Table 77. Asia-Pacific Respiratory Disorders Drug Market Size by Regions (2016-2021) & (US$ Million) Table 78. Asia-Pacific Respiratory Disorders Drug Market Size by Regions (2022-2027) & (US$ Million) Table 79. Respiratory Disorders Drug Market Size (US$ Million) in China, Breakdown by Type (2016-2021) Table 80. Respiratory Disorders Drug Market Size (US$ Million) in China, Breakdown by Type (2022-2027) Table 81. Respiratory Disorders Drug Market Size (US$ Million) in China, Breakdown by Application (2016-2021) Table 82. Respiratory Disorders Drug Market Size (US$ Million) in China, Breakdown by Application (2022-2027) Table 83. Respiratory Disorders Drug Market Size (US$ Million) in Japan, Breakdown by Type (2016-2021) Table 84. Respiratory Disorders Drug Market Size (US$ Million) in Japan, Breakdown by Type (2022-2027) Table 85. Respiratory Disorders Drug Market Size (US$ Million) in Japan, Breakdown by Application (2016-2021) Table 86. Respiratory Disorders Drug Market Size (US$ Million) in Japan, Breakdown by Application (2022-2027) Table 87. Respiratory Disorders Drug Market Size (US$ Million) in South Korea, Breakdown by Type (2016-2021) Table 88. Respiratory Disorders Drug Market Size (US$ Million) in South Korea, Breakdown by Type (2022-2027) Table 89. Respiratory Disorders Drug Market Size (US$ Million) in South Korea, Breakdown by Application (2016-2021) Table 90. Respiratory Disorders Drug Market Size (US$ Million) in South Korea, Breakdown by Application (2022-2027) Table 91. Respiratory Disorders Drug Market Size (US$ Million) in India, Breakdown by Type (2016-2021) Table 92. Respiratory Disorders Drug Market Size (US$ Million) in India, Breakdown by Type (2022-2027) Table 93. Respiratory Disorders Drug Market Size (US$ Million) in India, Breakdown by Application (2016-2021) Table 94. Respiratory Disorders Drug Market Size (US$ Million) in India, Breakdown by Application (2022-2027) Table 95. Respiratory Disorders Drug Market Size (US$ Million) in Australia, Breakdown by Type (2016-2021) Table 96. Respiratory Disorders Drug Market Size (US$ Million) in Australia, Breakdown by Type (2022-2027) Table 97. Respiratory Disorders Drug Market Size (US$ Million) in Australia, Breakdown by Application (2016-2021) Table 98. Respiratory Disorders Drug Market Size (US$ Million) in Australia, Breakdown by Application (2022-2027) Table 99. Respiratory Disorders Drug Market Size (US$ Million) in Taiwan, Breakdown by Type (2016-2021) Table 100. Respiratory Disorders Drug Market Size (US$ Million) in Taiwan, Breakdown by Type (2022-2027) Table 101. Respiratory Disorders Drug Market Size (US$ Million) in Taiwan, Breakdown by Application (2016-2021) Table 102. Respiratory Disorders Drug Market Size (US$ Million) in Taiwan, Breakdown by Application (2022-2027) Table 103. Respiratory Disorders Drug Market Size (US$ Million) in Indonesia, Breakdown by Type (2016-2021) Table 104. Respiratory Disorders Drug Market Size (US$ Million) in Indonesia, Breakdown by Type (2022-2027) Table 105. Respiratory Disorders Drug Market Size (US$ Million) in Indonesia, Breakdown by Application (2016-2021) Table 106. Respiratory Disorders Drug Market Size (US$ Million) in Indonesia, Breakdown by Application (2022-2027) Table 107. Key Players Respiratory Disorders Drug Revenue in Latin America (2020-2021) (US$ Million) Table 108. Latin America Respiratory Disorders Drug Market Size by Countries (2016-2021) & (US$ Million) Table 109. Latin America Respiratory Disorders Drug Market Size by Countries (2022-2027) & (US$ Million) Table 110. Respiratory Disorders Drug Market Size (US$ Million) in Mexico, Breakdown by Type (2016-2021) Table 111. Respiratory Disorders Drug Market Size (US$ Million) in Mexico, Breakdown by Type (2022-2027) Table 112. Respiratory Disorders Drug Market Size (US$ Million) in Mexico, Breakdown by Application (2016-2021) Table 113. Respiratory Disorders Drug Market Size (US$ Million) in Mexico, Breakdown by Application (2022-2027) Table 114. Respiratory Disorders Drug Market Size (US$ Million) in Brazil, Breakdown by Type (2016-2021) Table 115. Respiratory Disorders Drug Market Size (US$ Million) in Brazil, Breakdown by Type (2022-2027) Table 116. Respiratory Disorders Drug Market Size (US$ Million) in Brazil, Breakdown by Application (2016-2021) Table 117. Respiratory Disorders Drug Market Size (US$ Million) in Brazil, Breakdown by Application (2022-2027) Table 118. Respiratory Disorders Drug Market Size (US$ Million) in Argentina, Breakdown by Type (2016-2021) Table 119. Respiratory Disorders Drug Market Size (US$ Million) in Argentina, Breakdown by Type (2022-2027) Table 120. Respiratory Disorders Drug Market Size (US$ Million) in Argentina, Breakdown by Application (2016-2021) Table 121. Respiratory Disorders Drug Market Size (US$ Million) in Argentina, Breakdown by Application (2022-2027) Table 122. Key Players Respiratory Disorders Drug Revenue in Middle East & Africa (2020-2021) (US$ Million) Table 123. Middle East & Africa Respiratory Disorders Drug Market Size by Countries (2016-2021) & (US$ Million) Table 124. Middle East & Africa Respiratory Disorders Drug Market Size by Countries (2022-2027) & (US$ Million) Table 125. Respiratory Disorders Drug Market Size (US$ Million) in Turkey, Breakdown by Type (2016-2021) Table 126. Respiratory Disorders Drug Market Size (US$ Million) in Turkey, Breakdown by Type (2022-2027) Table 127. Respiratory Disorders Drug Market Size (US$ Million) in Turkey, Breakdown by Application (2016-2021) Table 128. Respiratory Disorders Drug Market Size (US$ Million) in Turkey, Breakdown by Application (2022-2027) Table 129. Respiratory Disorders Drug Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2016-2021) Table 130. Respiratory Disorders Drug Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2022-2027) Table 131. Respiratory Disorders Drug Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2016-2021) Table 132. Respiratory Disorders Drug Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2022-2027) Table 133. Respiratory Disorders Drug Market Size (US$ Million) in UAE, Breakdown by Type (2016-2021) Table 134. Respiratory Disorders Drug Market Size (US$ Million) in UAE, Breakdown by Type (2022-2027) Table 135. Respiratory Disorders Drug Market Size (US$ Million) in UAE, Breakdown by Application (2016-2021) Table 136. Respiratory Disorders Drug Market Size (US$ Million) in UAE, Breakdown by Application (2022-2027) Table 137. AstraZeneca Company Details Table 138. AstraZeneca Business Overview Table 139. AstraZeneca Revenue in Respiratory Disorders Drug Business (2016-2021) & (US$ Million) Table 140. AstraZeneca Respiratory Disorders Drug Respiratory Disorders Drug Product Table 141. AstraZeneca Recent Development Table 142. MSD Company Details Table 143. MSD Business Overview Table 144. MSD Revenue in Respiratory Disorders Drug Business (2016-2021) & (US$ Million) Table 145. MSD Respiratory Disorders Drug Product Table 146. MSD Recent Development Table 147. Boehringer Ingelheim Company Details Table 148. Boehringer Ingelheim Business Overview Table 149. Boehringer Ingelheim Revenue in Respiratory Disorders Drug Business (2016-2021) & (US$ Million) Table 150. Boehringer Ingelheim Respiratory Disorders Drug Product Table 151. Boehringer Ingelheim Recent Development Table 152. Biogen Company Details Table 153. Biogen Business Overview Table 154. Biogen Revenue in Respiratory Disorders Drug Business (2016-2021) & (US$ Million) Table 155. Biogen Respiratory Disorders Drug Product Table 156. Biogen Recent Development Table 157. Pfizer Company Details Table 158. Pfizer Business Overview Table 159. Pfizer Revenue in Respiratory Disorders Drug Business (2016-2021) & (US$ Million) Table 160. Pfizer Respiratory Disorders Drug Product Table 161. Pfizer Recent Development Table 162. Teva Company Details Table 163. Teva Business Overview Table 164. Teva Revenue in Respiratory Disorders Drug Business (2016-2021) & (US$ Million) Table 165. Teva Respiratory Disorders Drug Product Table 166. Teva Recent Development Table 167. Novartis Company Details Table 168. Novartis Business Overview Table 169. Novartis Revenue in Respiratory Disorders Drug Business (2016-2021) & (US$ Million) Table 170. Novartis Respiratory Disorders Drug Product Table 171. Novartis Recent Development Table 172. Johnson & Johnson Company Details Table 173. Johnson & Johnson Business Overview Table 174. Johnson & Johnson Revenue in Respiratory Disorders Drug Business (2016-2021) & (US$ Million) Table 175. Johnson & Johnson Respiratory Disorders Drug Product Table 176. Johnson & Johnson Recent Development Table 177. Eli Lilly Company Details Table 178. Eli Lilly Business Overview Table 179. Eli Lilly Revenue in Respiratory Disorders Drug Business (2016-2021) & (US$ Million) Table 180. Eli Lilly Respiratory Disorders Drug Product Table 181. Eli Lilly Recent Development Table 182. Otsuka Company Details Table 183. Otsuka Business Overview Table 184. Otsuka Revenue in Respiratory Disorders Drug Business (2016-2021) & (US$ Million) Table 185. Otsuka Respiratory Disorders Drug Product Table 186. Otsuka Recent Development Table 187. Merck Company Details Table 188. Merck Business Overview Table 189. Merck Revenue in Respiratory Disorders Drug Business (2016-2021) & (US$ Million) Table 190. Merck Respiratory Disorders Drug Product Table 191. Merck Recent Development Table 192. Takeda Company Details Table 193. Takeda Business Overview Table 194. Takeda Revenue in Respiratory Disorders Drug Business (2016-2021) & (US$ Million) Table 195. Takeda Respiratory Disorders Drug Product Table 196. Takeda Recent Development Table 197. FibroGen Company Details Table 198. FibroGen Business Overview Table 199. FibroGen Revenue in Respiratory Disorders Drug Business (2016-2021) & (US$ Million) Table 200. FibroGen Respiratory Disorders Drug Product Table 201. FibroGen Recent Development Table 202. Amgen Company Details Table 203. Amgen Business Overview Table 204. Amgen Revenue in Respiratory Disorders Drug Business (2016-2021) & (US$ Million) Table 205. Amgen Respiratory Disorders Drug Product Table 206. Amgen Recent Development Table 207. Dr. Reddy's Laboratories Company Details Table 208. Dr. Reddy's Laboratories Business Overview Table 209. Dr. Reddy's Laboratories Revenue in Respiratory Disorders Drug Business (2016-2021) & (US$ Million) Table 210. Dr. Reddy's Laboratories Respiratory Disorders Drug Product Table 211. Dr. Reddy's Laboratories Recent Development Table 212. Dainippon Sumitomo Company Details Table 213. Dainippon Sumitomo Business Overview Table 214. Dainippon Sumitomo Revenue in Respiratory Disorders Drug Business (2016-2021) & (US$ Million) Table 215. Dainippon Sumitomo Respiratory Disorders Drug Product Table 216. Dainippon Sumitomo Recent Development Table 217. Abbott Company Details Table 218. Abbott Business Overview Table 219. Abbott Revenue in Respiratory Disorders Drug Business (2016-2021) & (US$ Million) Table 220. Abbott Respiratory Disorders Drug Product Table 221. Abbott Recent Development Table 222. Horizon Pharma Company Details Table 223. Horizon Pharma Business Overview Table 224. Horizon Pharma Revenue in Respiratory Disorders Drug Business (2016-2021) & (US$ Million) Table 225. Horizon Pharma Respiratory Disorders Drug Product Table 226. Horizon Pharma Recent Development Table 227. Zambon Company Details Table 228. Zambon Business Overview Table 229. Zambon Revenue in Respiratory Disorders Drug Business (2016-2021) & (US$ Million) Table 230. Zambon Respiratory Disorders Drug Product Table 231. Zambon Recent Development Table 232. Moehs Company Details Table 233. Moehs Business Overview Table 234. Moehs Revenue in Respiratory Disorders Drug Business (2016-2021) & (US$ Million) Table 235. Moehs Respiratory Disorders Drug Product Table 236. Moehs Recent Development Table 237. Pharmazell Company Details Table 238. Nippon Rika Company Details Table 239. Chengyi Pharma Company Details Table 240. Wuhan Grand Hoyo Company Details Table 241. Manus Aktteva Biopharma Company Details Table 242. Beijing Jiuhe Pharmaceutical Company Details Table 243. Daiichi Sankyo Pharmaceutical Company Details Table 244. Sinopharm Company Details Table 245. CTTQ Company Details Table 246. Yangtze River Pharmaceutical Group Company Details Table 247. Research Programs/Design for This Report Table 248. Key Data Information from Secondary Sources Table 249. Key Data Information from Primary Sources List of Figures Figure 1. Global Respiratory Disorders Drug Market Share by Type: 2020 & 2027 Figure 2. Capsule Features Figure 3. Suspension Agent Features Figure 4. Injection Features Figure 5. Gas (Powder) Mist Features Figure 6. Tablets Features Figure 7. Solution Features Figure 8. Granules Features Figure 9. Dropping Pill Features Figure 10. Patch Features Figure 11. Global Respiratory Disorders Drug Market Share by Application: 2020 & 2027 Figure 12. Clearing Away Heat And Detoxifying Drugs Case Studies Figure 13. Expectorant Case Studies Figure 14. Cold Medicine Case Studies Figure 15. Antiasthmatic Case Studies Figure 16. COPD Treatment Medicine Case Studies Figure 17. Cough Medicine Case Studies Figure 18. Respiratory Stimulant Case Studies Figure 19. Other Case Studies Figure 20. Respiratory Disorders Drug Report Years Considered Figure 21. Global Respiratory Disorders Drug Market Share by Regions: 2016 VS 2021 VS 2027 Figure 22. Global Respiratory Disorders Drug Market Size YoY Growth 2016-2027 (US$ Million) Figure 23. Global Respiratory Disorders Drug Market Share by Regions (2022-2027) Figure 24. Global Respiratory Disorders Drug Market Share by Players in 2020 Figure 25. Global Top Respiratory Disorders Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Disorders Drug as of 2020) Figure 26. The Top 10 and 5 Players Market Share by Respiratory Disorders Drug Revenue in 2020 Figure 27. North America Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. U.S. Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Canada Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Germany Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. China Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Japan Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. South Korea Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. India Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Australia Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Taiwan Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Indonesia Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Thailand Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Malaysia Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Philippines Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Vietnam Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Mexico Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Argentina Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Turkey Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Saudi Arabia Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. UAE Respiratory Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

AstraZeneca MSD Boehringer Ingelheim Biogen Pfizer Teva Novartis Johnson & Johnson Eli Lilly Otsuka Merck Takeda FibroGen Amgen Dr. Reddy's Laboratories Dainippon Sumitomo Abbott Horizon Pharma Zambon Moehs Pharmazell Nippon Rika Chengyi Pharma Wuhan Grand Hoyo Manus Aktteva Biopharma Beijing Jiuhe Pharmaceutical Daiichi Sankyo Pharmaceutical Sinopharm CTTQ Yangtze River Pharmaceutical Group